Xcout Intel
Twelve
Twelve, Inc. is a privately held medical device company based in Redwood City, California, focused on the development of innovative cardiovascular technologies.
Subscribe to see Twelve’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Twelve at a glance
Twelve is a biotech company headquartered in United States. Its most recent funding round raised $35.2M in April 2015. Xcout recorded 15 job postings from Twelve in the last 90 days, naming tools such as Oracle ERP, SAP.
Twelve funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $35.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Twelve
Xcout recorded 15 job postings from Twelve in the last 90 days, from a hiring record Xcout has kept since July 2026.
Tools named in Twelve's job postings
The weekly hiring trend, the roles and locations behind it — see Twelve's hiring signals →
Twelve competitors
A few of Twelve's closest competitors — see the full list of competitors and alternatives →
InCube Labs is a life sciences venture lab and technology incubator headquartered in Silicon Valley, California, focused on creating medical device and biotechnology portfolio companies.
CoreMedic is a privately held medical device company founded in Switzerland that develops therapies and devices aimed at treating heart valve diseases.
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.
Sutura is a medical device company that develops minimally invasive and vascular suturing and vessel closure devices. The company operates within the surgical and medical device industry.
The Blue Box Biomedical Solutions is a biomedical company headquartered in Barcelona, Spain, with a US office in Menlo Park, California. The company develops specialized health solutions and medical technology.
Nephera is an Israeli development-stage medical device company founded in 2008 and headquartered in Misgav. The company focuses on therapeutic devices designed to improve and maintain kidney function in patients with acute and congestive heart failure.
Get Twelve's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Twelve in Xcout Intel
- 1 funding round with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access